chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I63.9 - Cerebrovascular accident (CVA), unspecified mechanism (CMS/HCC) E87.1 - Hypo-osmolality and hyponatremia R29.810 - Facial weakness
Episodes of intussusception after first dose of rotavirus vaccine, parents were not made aware of any complications or any information about the vaccine, mom asked MD about abdominal complications with 4 month vaccine, MD stated "nothing we are giving have any abdominal complications". Baby received vaccine on Dec 19 and had first episode on Dec 24 and second episode on Dec 29. Intussusception self resolved before I could get him to the ER both times.
Moderate anaphylaxis reaction per urgent care provider. Developed severe hives and swelling, fever, severe headache 2 days after vaccination. Was treated with Benadryl, Solumedrol IM, and Prednisone taper at local urgent care center.
No adverse event; Patient received 0.5ml of the "regular" Moderna COVID19 vaccine instead of the bivalent booster; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received 0.5ml of the "regular" Moderna COVID19 vaccine instead of the bivalent booster) and NO ADVERSE EVENT (No adverse event) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052b22a) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Oct-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 08-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Patient received 0.5ml of the "regular" Moderna COVID19 vaccine instead of the bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient received 0.5ml of the "regular" Moderna COVID19 vaccine instead of the bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient received 0.5ml of the "regular" Moderna COVID19 vaccine instead of the bivalent booster).    No concomitant medication was reported.     No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-657011 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-657011:Case for patient patient 2.
Pt woke up with rash from waist up 11/20/03. circular urticarial lesions at injection site and elsewhere. Seen in ER for worsening rash 11/21/03 and in office. Dx erythema multiforme. rx Atarax was on Benadryl. Fever 103.1 (ax) on 11/21/03. 104 on 11/22/03. The discharge summary received on 3/22/04 states vomiting, gastroenteritis, fever, abdominal pain, and runny nose.
Rash at site; Swelling; Stinging; This case was reported by a consumer via interactive digital media and described the occurrence of injection site rash in a patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   On an unknown date, the patient received Meningococcal B vaccine. On an unknown date, unknown after receiving Meningococcal B vaccine, the patient experienced injection site rash, swelling and stinging. On an unknown date, the outcome of the injection site rash, swelling and stinging were unknown.   It was unknown if the reporter considered the injection site rash, swelling and stinging to be related to Meningococcal B vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received Meningitis B shot and experienced rash at site, swelling, stinging.  The reporter asked what was normal. The follow-up would not possible as no contact details were available.
My throat immediately started to swell; This is a spontaneous report received from a contactable consumer (patient). A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number and expiry date were not reported) via an unspecified route of administration into left arm, at the age of 38-year-old, on unknown date, at dose 2 single for covid-19 immunisation.  Historical vaccine included BNT162B2 (COMIRNATY, solution for injection; lot numbers and expiry dates were not reported) via an unspecified route of administration into left arm, on unknown date, at dose 1, single for covid-19 immunisation. Patient medical history includes shellfish allergy. The patient didn't have any hospitalization.The patient concomitant medications were not reported. The patient is not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have prior COVID vaccination and was not tested post vaccination. The patient experienced throat immediately started to swell. The patient didn't have any treatment in response to the event. The outcome of the event was recovered at the time of report.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
exaggerated menstrual flow (menstrual bleeding) after 2 or 3 months of the 2nd dose
fever; body aches; knocked me out; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced fever, general body pain and feeling abnormal. On an unknown date, the outcome of the fever, general body pain and feeling abnormal were unknown.   It was unknown if the reporter considered the fever, general body pain and feeling abnormal to be related to Shingles vaccine.  Additional details provided were as follows: Age at vaccination was not reported. The case was reported by patient himself/herself. The patient received 2nd dose which knocked him/her out and experienced fever and body aches. Follow-up would not be possible as no contact details available.
Complaint of racing HR, no other symptoms, no SOB. Verbalized feeling nervous/anxious with some vision changes. PMH: HIV+ and hyperlipidemia. 0735: HR 110, BP 125/80 L arm, RR 17. 0740: HR 98. Did not take am medications, no breakfast or water, only 2 sips of coffee. Gave him water and he stated feeling better at 0800 and left site and stated partner would drive him home. No treatments administered.
Felt very bad; Dripping nose; Rash is itching severely and more in the edges; Rash is pinkish in color; This Tuesday I started to get a little circle of a rash where needle went it, that kept growing larger; Headache; Was tired; RASH today it is size of a baseball; like sun burned RASH; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt very bad), RHINORRHOEA (Dripping nose), VACCINATION SITE PRURITUS (Rash is itching severely and more in the edges), VACCINATION SITE ERYTHEMA (Rash is pinkish in color) and VACCINATION SITE RASH (This Tuesday I started to get a little circle of a rash where needle went it, that kept growing larger) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included OMEPRAZOLE for an unknown indication.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, the patient experienced FEELING ABNORMAL (Felt very bad), RHINORRHOEA (Dripping nose), VACCINATION SITE PRURITUS (Rash is itching severely and more in the edges), VACCINATION SITE ERYTHEMA (Rash is pinkish in color), VACCINATION SITE RASH (This Tuesday I started to get a little circle of a rash where needle went it, that kept growing larger), HEADACHE (Headache), FATIGUE (Was tired), VACCINATION SITE SWELLING (RASH today it is size of a baseball) and VACCINATION SITE PAIN (like sun burned RASH). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg. At the time of the report, FEELING ABNORMAL (Felt very bad), RHINORRHOEA (Dripping nose), VACCINATION SITE PRURITUS (Rash is itching severely and more in the edges), VACCINATION SITE ERYTHEMA (Rash is pinkish in color), VACCINATION SITE RASH (This Tuesday I started to get a little circle of a rash where needle went it, that kept growing larger), HEADACHE (Headache), FATIGUE (Was tired), VACCINATION SITE SWELLING (RASH today it is size of a baseball) and VACCINATION SITE PAIN (like sun burned RASH) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-245608 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Reporter's contact information added and lot number of vaccine updated from 022C219 to 022C21A.
2JUN95 pt vax that day when mom got home w/pt noted sl swelling lt arm w/white blister appearance;mom phoned MD & felt would be OK;13JUN95 pt had small raised reddened areas on lt arm around site of inj;15JUN95 pt saw MD allerg reaction
Post first dose of pfizer covid vaccine I had 2-3 days of intermittent headaches starting approximately 4 hours after dose and also 4-5 days of intermittent lightheadedness. I developed redness at injection site 4 days post dose and it is still present as of today even though it seems to be fading. Site is still painful to the touch.
PATIENT EXPERIENCED LOCALIZED PIN AND SWELLING IN THE RIGHT DELTOID REGION AND THIS INCREASED OVER TIME UNTIL SHE HAD LOSS OF THE ABILITY TO USE THE ARM DUE TO PAIN AND INFLAMMATION. DIAGNOSED WITH BICEPS TENDONITIS WITH CELLULITIS/ ABSCESS.
Headache began in late afternoon, unwell feeling.  Headache in frontal lobe disrupted sleep all night.  Had fever by morning, highest checked was 101.7.  Stayed in bed until noon.  Took aspirin later in 15th, fever slowly diminished to about 99 by evening.  Stayed in bed all day on 15th.  Took a Nyquil to help with sleep on evening of the 15th. Woke up feeling well on the 16th.  Had some nasal congestion in evening couple of days, took Dayquil 2 following days.  Then all well.
Severe itching especially in hands, feet, and back.  Treated with Benadryl and cortisone 2% cream.  Very dark orange urine.
Squamous cell carcinoma around the right eye; This spontaneous case was reported by a patient and describes the occurrence of SQUAMOUS CELL CARCINOMA (Squamous cell carcinoma around the right eye) in an elderly female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced SQUAMOUS CELL CARCINOMA (Squamous cell carcinoma around the right eye) (seriousness criterion medically significant). The patient was treated with Surgery (Procedure around a delicate part of her eye for the carcinoma) for Squamous cell carcinoma. At the time of the report, SQUAMOUS CELL CARCINOMA (Squamous cell carcinoma around the right eye) outcome was unknown.            Concomitant medication was not provided. Treatment information was not reported. Patient had a serious underlying eye condition. Patient was administered with primary serious of Moderna and her 2nd booster was Pfizer BioNTech COVID-19 vaccine. Company comment: This spontaneous case concerns an elderly female patient, with no reported medical history, who experienced the unexpected, serious (medically significant) event of squamous cell carcinoma after a dose of mRNA-1273 Bivalent vaccine. The patient received Moderna vaccine as primary series and first booster. A procedure around a delicate part of her eye for the carcinoma was performed. No further details for medical review were reported.  At the time of the latest report the outcome of the event was unknown. The benefit-risk relationship of mRNA-1273 Bivalent vaccine is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2023-702511 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-702511:(Case for friends)
SWOLLEN LEGS AND FEET; PAIN IN NECK; PAIN IN HIPS; PAIN IN ARMS; EXHAUSTED; This spontaneous report received from a patient concerned a 60 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced swollen legs and feet, pain in neck, pain in hips, pain in arms, and exhausted. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from exhausted, pain in hips, pain in arms, pain in neck, and swollen legs and feet. This report was non-serious.
NEARLY DIED; LIPS AND TONGUE WENT NUMB; This spontaneous report received from a consumer via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced nearly died, and lips and tongue went numb. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the lips and tongue went numb and nearly died was not reported. This report was non-serious. This case, from the same reporter is linked to 20221243340, 20221243606, 20221243356, 20221245881, 20221245816 and 20221245969.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as the case assessed as non-serious.
On 4/12/21 woke up at 3 am with excruciating pain in my legs and numbing and tingling in both arms and is still present on 4/13/21
No adverse effect with vaccine.  on 2-3-2022 symptomatic with flu like symptoms.  Urgent care COVID-19 test positive.  Received call from CDC-VSAFE Reg @ 2-4-2022 -12:09 CST and told to fill out this form.
Client received Moderna #1.   Walked to observation area and sat. 5 minutes into observation felt lightheaded and dizzy.  He then remembers waking up to transfer to a wheelchair. He was taken to EMS area where vital signs were normal.  Client was monitored until symptoms improved and client was able to leave the clinic independently.
Golf ball size swelling on Left armpit,Bubbling and cyst; Missed 2nd dose of Moderna vaccine on recommended interval; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Golf ball size swelling on Left armpit,Bubbling and cyst) and PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose of Moderna vaccine on recommended interval) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027C21A and 036B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose of Moderna vaccine on recommended interval). On 08-Apr-2021, the patient experienced SWELLING (Golf ball size swelling on Left armpit,Bubbling and cyst). At the time of the report, SWELLING (Golf ball size swelling on Left armpit,Bubbling and cyst) had not resolved and PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose of Moderna vaccine on recommended interval) had resolved.            No concomitant medications reported. The patient received second Moderna vaccine on right arm on 18May2021 and no symptom after vaccine administration. No treatment information was provided. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
3 inches in diameter, round, light pink color where the injection site, little hot, and little itchy.; 3 inches in diameter, round, light pink color where the injection site, little hot, and little itchy.; 3 inches in diameter, round, light pink color where the injection site, little hot, and little itchy.; 3 inches in diameter, round, light pink color where the injection site, little hot, and little itchy.; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-May-2021 and was forwarded to Moderna on 24-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (3 inches in diameter, round, light pink color where the injection site, little hot, and little itchy.), VACCINATION SITE SWELLING (3 inches in diameter, round, light pink color where the injection site, little hot, and little itchy.), VACCINATION SITE ERYTHEMA (3 inches in diameter, round, light pink color where the injection site, little hot, and little itchy.) and VACCINATION SITE PRURITUS (3 inches in diameter, round, light pink color where the injection site, little hot, and little itchy.) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0ZZCZ1A and 048B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-May-2021, the patient experienced VACCINATION SITE WARMTH (3 inches in diameter, round, light pink color where the injection site, little hot, and little itchy.), VACCINATION SITE SWELLING (3 inches in diameter, round, light pink color where the injection site, little hot, and little itchy.), VACCINATION SITE ERYTHEMA (3 inches in diameter, round, light pink color where the injection site, little hot, and little itchy.) and VACCINATION SITE PRURITUS (3 inches in diameter, round, light pink color where the injection site, little hot, and little itchy.). At the time of the report, VACCINATION SITE WARMTH (3 inches in diameter, round, light pink color where the injection site, little hot, and little itchy.), VACCINATION SITE SWELLING (3 inches in diameter, round, light pink color where the injection site, little hot, and little itchy.), VACCINATION SITE ERYTHEMA (3 inches in diameter, round, light pink color where the injection site, little hot, and little itchy.) and VACCINATION SITE PRURITUS (3 inches in diameter, round, light pink color where the injection site, little hot, and little itchy.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient takes a lot of medications but patient did not provide agent with the medications list because it is a long list. Concomitant medications and treatment information was not provided.
8hr post vax-high pitch screaming for 2hr, leg began to swell, a red triangular induration appeared @ vax site;would not bear weight;
77 y/o with Afib and lung cancer given H1N1 (Sanofi) on 11/3/09- Died. 11/5/09-prob. heart attack.   11/06/09 Medical records received. DOS 08/21/08-03/24/09.  PCP office notes.  Visits note looked well, unremarkable PEs with well healed surgical scars, clear bronchial to minimal wheeze, CBCs WNL w/some low 02 sats (92% on R/A). Extrems trace PTE, until 03/24/09. DX bad cold w/ white mucus and cough. Nausea, low grade fever. Lung sounds benign. Mild leukocytosis, possible infection. Tx Levaquin. 4/28/09 Congestion continued, thick mucus, worse since pneumonia. Bronchial w/minimal wheezes. CBC WNL. EKG sinus rhythm, systolic murmur.  Subsequent visits showed 02 sat 91%, weight loss.  11/03 occasional SOB, H1N1 vaccine given.    Labs & Diags EKG- normal, sinus mechanism, bradycardia 48.    12/17/09 Death Certificate received. DOD 11/05/09. Cause of Death. Myocardial infarction. Other information abstracted: Other medical conditions - lung cancer, atrial fibrillation.
displaying odd behavior; had a due second dose last March 19, he didn't want to take it and so he missed the dose; This is a spontaneous report received from a . A contactable consumer (patient's mother) reported for a 48-year-old male patient received first dose of BNT162B2 (Pfizer COVID-19 Vaccine, Formulation: solution for injection, Batch/Lot number: unknown), via unspecified route of administration on 17Feb2021 as single dose for COVID-19 immunization. Patient's medical history included head injury, road accident (had a head injury because of a car accident years ago). The patient concomitant medications were not reported. Reporter stated patient had a due second dose last 19Mar2021 and he did not want to take it and so he missed the dose. After a week of receiving the vaccine, he is displaying odd behavior and he was admitted in a psychiatric hospital on 27Mar2021. Reporter asked is there a 42 day window after receiving the first shot to get the second shot. The outcome of event was unknown.  Information about lot/batch number has been requested.
Delayed and progressive swelling, erythema, and induration around vaccine site.  This started on day 2 after the initial dose and is persistent at 10 days.
Patient got FLUAD shot 12/01/2017 and called in the evening complaining of severe pain in left arm, unable to move arm completely. By todays day, 12-07-17, patient feels much better but still have some pain in left arm.